This list is an analysis based on recent market events. It's not an investment recommendation.
About
NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. It offers rapid diagnostic tests, such as family planning, and preventive healthcare line products. The company also develops and commercializes immunochromatographic lateral flow tests; and tests for hospitals and medical practices. The company is headquartered in Marburg, Germany.
The current price of NNGRF is $12.76 USD — it has decreased by -31.04% in the past 24 hours. Watch NanoRepro stock price performance more closely on the chart.
What is NanoRepro stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange NanoRepro stocks are traded under the ticker NNGRF.
What were NanoRepro earnings last quarter?▼
NNGRF earnings for the last quarter are 1.19 USD per share, whereas the estimation was 0 USD resulting in a +∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is NanoRepro revenue for the last year?▼
NanoRepro revenue for the last year amounts to 40.65M USD.
What is NanoRepro net income for the last year?▼
NNGRF net income for the last year is -4M USD.
Does NanoRepro pay dividends?▼
Yes, NNGRF dividends are paid annual. The last dividend per share was 0.16 USD. As of today, Dividend Yield (FWD)% is 0%.